薬剤特異性,シナジー,および対抗性 超高容量ポリ (オキサゾリン) /ポリ (オキサジン) 基製剤
Michael M Lübtow1, Lukas Hahn1, Malik Salman Haider1
1Functional Polymer Materials, Chair for Chemical Technology of Material Synthesis and the Bavarian Polymer Institute, University of Würzburg , Röntgenring 11, 97070 Würzburg, Germany.
Journal of the American Chemical Society
|July 28, 2017
まとめ
ポリマーミセルは 薬の投与と触媒に精密に調整できます 微妙な構造の変化は,薬剤溶解を大幅に変化させ,特定の宿主-ゲストの相互作用を明らかにします.
科学分野:
- ポリマー化学
- 材料科学
- ナノテクノロジー
背景:
- ポリマーミセルは様々な用途に 独特のナノスケール環境を作り出します
- アムフィフィルの構造を微調整することで ミセルの微環境を正確に制御できます
- 水性および水害性特性は重要なものですが,詳細な特徴付けには不十分です.
研究 の 目的:
- 構造的に類似したポリー−−オクサゾリンとポリー−−オクサジンの溶解能力を調査する.
- カルキュミンとパクリタキセルとの相互作用を評価する.
- ポリマーミセル内の宿主-ゲストの相互作用に対する微妙な構造変化の影響を理解する.
主な方法:
- 構造的に類似したポリ・オクサゾリンとポリ・オクサジンの小さなライブラリを合成する.
- カルキュミンとパクリタキセルの溶解能力の評価
- 同製剤における相乗効果と対抗効果の分析
主要な成果:
- シングルメチレン群の交換でも,薬剤溶解の有意で直交的な特異性は観察された.
- 同製薬の深いシナジスティックおよび反抗的溶解パターンが出現した.
- ポリマーミセルの宿主-ゲストの特異性を示した.
結論:
- ポリマーアンフィフィルの微妙な構造の変化は,重要で特定の宿主-ゲストの相互作用につながります.
- ポリマーミセルのマイクロ環境のチューニングは,薬物の投与とミセラ触媒の最適化に不可欠です.
- この発見は,ナノスケールのシステムにおける宿主-ゲスト化学の理解を進めるものです.
さらに関連する動画
関連する概念動画
01:14Agonism and Antagonism: Quantification
1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K
01:30Combined Effects of Drugs: Antagonism
11.9K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.9K
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
788
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
788
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
57
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
57
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
208
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
208
01:25Dose-Response Relationship: Selectivity and Specificity
10.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.1K